1 |
Liu Z, Shen Y, Cui N, Yang J. Clinical observation of immunity for severe acute pancreatitis. Inflammation. 2011;34(5):426-31.
DOI
ScienceOn
|
2 |
Liang JQ, Mi SQ, Wang NS. [Anticoagulative effect and antiplatelet aggregation effect of combination of Hirudo and Tabanus on rat model of blood stasis syndrome]. Zhong Yao Cai. 2009;32(9):1347-50. Chinese.
|
3 |
Ma H, Yang J, Nan SL, Gong JN, Liu XF. [Effects of Yangyin Shengjin Decoction on hemorheological parameters and coagulation factors in model rabbits with syndrome of excessive heat consuming body fluid and blood stasis]. Zhong Xi Yi Jie He Xue Bao. 2005;3(1):39-42. Chinese.
DOI
|
4 |
Meng MB, Wen QL, Cui YL, She B, Zhang RM. Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Explore (NY). 2011;7(1):37-43.
DOI
ScienceOn
|
5 |
Zhao CL, Peng LJ, Zhang ZL, Zhang T, Li HM. [Effect of acupuncture on the activity of the peripheral blood T lymphocyte subsets and NK cells in patients with colorectal cancer liver metastasis]. Zhongguo Zhen Jiu. 2010;30(1):10-2. Chinese.
|
6 |
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649-55.
DOI
ScienceOn
|
7 |
Luo J, Ling Z, Mao W. [Circulating lymphocyte subsets in patients with lung cancer and their prognostic value]. Zhongguo Fei Ai Za Zhi. 2011;14(8):669-73. Chinese.
|
8 |
Soygur T, Beduk Y, Baltaci S, Yaman O, Tokgoz G. The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy. BJU Int. 1999;84(9):1069-72.
|
9 |
Lwaleed BA, Cooper AJ, Voegeli D, Getliffe K. Tissue factor: a critical role in inflammation and cancer. Biol Res Nurs. 2007;9(2):97-107.
DOI
|
10 |
Gillgrass A, Ashkar A. Stimulating natural killer cells to protect against cancer: recent developments. Expert Rev Clin Immunol. 2011;7(3):367-82.
DOI
ScienceOn
|
11 |
Hus I, Staroslawska E, Bojarska-Junak A, Dobrzynska-Rutkowska A, Surdacka A, Wdowiak P, et al. CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma. Folia Histochem Cytobiol. 2011;49(1):183-7.
DOI
|
12 |
Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, et al. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol. 2007;18(7):1209-15.
DOI
ScienceOn
|
13 |
Stewart DA, Guo D, Luider J, Auer I, Klassen J, Morris D, et al. The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization. Bone Marrow Transplant. 2001;27(12):1237-43.
DOI
|
14 |
Shen Y, Lu C, Tian W, Wang L, Cui B, Jiao Y, et al. Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer. Int J Oncol. 2012;40(4):1285-90.
|
15 |
Konjevic G, Radenkovic S, Srdic T, Jurisic V, Stamatovic Lj, Milovic M. Association of decreased NK cell activity and expression with pSTAT dysregulation in breast cancer patients. J BUON. 2011;16(2):219-26.
|
16 |
Boccaccio C, Sabatino G, Medico E, Girolami F, Follenzi A, Reato G, et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature. 2005;434(7031):396-400.
DOI
ScienceOn
|
17 |
Rong Y, Post DE, Pieper RO, Durden DL, Van Meir EG, Brat DJ. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res. 2005;65(4):1406-13.
DOI
ScienceOn
|
18 |
Stadnisky MD, Xie X, Coats ER, Bullock TN, Brown MG. Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity. Blood. 2011;117(19):5133-41.
DOI
ScienceOn
|
19 |
Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117(5):1175-83.
DOI
ScienceOn
|
20 |
Reynes G, Vila V, Martin M, Parada A, Fleitas T, Reganon E, et al. Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol. 2011;102(1):35-41.
DOI
|
21 |
Fernandez PM, Patierno SR, Rickles FR. Tissue factor and fibrin in tumor angiogenesis. Semin Thromb Hemost. 2004;30(1):31-44.
|
22 |
Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW. Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost. 2007;5:246-54.
DOI
ScienceOn
|
23 |
Palumbo JS. Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination. Semin Thromb Hemost. 2008;34(2):154-60.
DOI
ScienceOn
|
24 |
Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest. 2003;124(3 Suppl): 58S-68S.
DOI
ScienceOn
|
25 |
Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol. 2004;5(11):655-63.
DOI
ScienceOn
|
26 |
Liu L, Duan JA, Tang Y, Guo J, Yang N, Ma H, et al. Taoren-Honghua herb pair and its main components promoting blood circulation through influencing on hemorheology, plasma coagulation and platelet aggregation. J Ethnopharmacol. 2012;139(2):381-7.
DOI
ScienceOn
|
27 |
Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med. 2004;10(5):502-9.
DOI
ScienceOn
|
28 |
Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, et al. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol. 1998;152(2):399-411.
|
29 |
Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 2005;105(4):1734-41.
DOI
ScienceOn
|
30 |
Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, et al. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A. 1999;96(15):8663-8.
DOI
|
31 |
Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2(2):209-15.
DOI
ScienceOn
|
32 |
Hair GA, Padula S, Zeff R, Schmeizl M, Contrino J, Kreutzer DL, et al. Tissue factor expression in human leukemic cells. Leuk Res. 1996;20(1):1-11.
DOI
ScienceOn
|
33 |
Guan M, Jin J, Su B, Liu WW, Lu Y. Tissue factor expression and angiogenesis in human glioma. Clin Biochem. 2002;35(4):321-5.
DOI
ScienceOn
|
34 |
Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K, et al. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer. 1999;79(3-4):472-7.
DOI
ScienceOn
|
35 |
Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994;94(3):1320-7.
DOI
ScienceOn
|
36 |
Nakasaki T, Wada H, Shigemori C, Miki C, Gabazza EC, Nobori T, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002;69(4):247-4.
DOI
ScienceOn
|